Skip to main content

potassium

Generic: POTASSIUM CHLORIDE·Brand: K+10, K+8, K-LEASE, K-TAB, KAON CL, KAON CL-10, KLOR-CON, KLOR-CON M10, KLOR-CON M15, KLOR-CON M20, KLOTRIX, MICRO-K, MICRO-K 10, MICRO-K LS, POKONZA, POTASSIUM ACETATE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE 10MEQ, POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE 20MEQ, POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE 40MEQ, POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE IN PLASTIC CONTAINER, POTASSIUM CITRATE, POTASSIUM PHOSPHATES, POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE, SLOW-K, TEN-K, UROCIT-K

potassium: sourced relationships with 1 company · 1 FDA decision.

potassium evidence translation

What we can confirm

What it means

Source-backed records connect potassium to ANIP; that link alone does not prove the drug works.

What to watch

Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected

Prepared research question

How could potassium → ANIP affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

Dated Pipeline Records (1)
CompanyDated record stage
ANI PHARMACEUTICALS INC (ANIP)
Reported 2020-01-14 · Current development: unknownSource
Approved
FDA Decisions1 records
ANDA212779UNKNOWNStandardOralTablet, Extended Release

Frequently asked questions

Which companies have sourced relationships with potassium?

potassium has dated SEC/FDA relationship records for ANI PHARMACEUTICALS INC.

What is potassium's latest FDA decision?

The most recent tracked FDA decision for potassium is Approval, dated January 14, 2020.